These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10494329)

  • 1. [Screening policy for travellers from Rotterdam for hepatitis A antibodies prior to eventual immunization: favourable cost-benefit ratio].
    Reintjes R; Bosman A; de Zwart O
    Ned Tijdschr Geneeskd; 1999 Aug; 143(35):1777-80. PubMed ID: 10494329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effective analysis of hepatitis A prevention in Ireland.
    Rajan E; Shattock AG; Fielding JF
    Am J Gastroenterol; 2000 Jan; 95(1):223-6. PubMed ID: 10638588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing for antibody to hepatitis A to decrease the cost of hepatitis A prophylaxis with immune globulin or hepatitis A vaccines.
    Bryan JP; Nelson M
    Arch Intern Med; 1994 Mar; 154(6):663-8. PubMed ID: 8129500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence and direct costs of pre-immunization testing for hepatitis A in general practice.
    Buckley D; Fahey T; Bevan G
    Br J Gen Pract; 1996 Sep; 46(410):541-2. PubMed ID: 8917876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of hepatitis A in Dutch hemophilia patients.
    Mauser-Bunschoten EP; Zaaijer HL; van Drimmelen AA; van den Berg HM; Roosendaal G; Lelie PN
    Thromb Haemost; 1995 Aug; 74(2):616-8. PubMed ID: 8584994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age related seroprevalence of antibodies to hepatitis A virus in Hyderabad, India.
    Joshi N; Yr NK; Kumar A
    Trop Gastroenterol; 2000; 21(2):63-5. PubMed ID: 10881625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An economic analysis of different strategies of immunization against hepatitis A virus in developed countries.
    Das A
    Hepatology; 1999 Feb; 29(2):548-52. PubMed ID: 9918934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevalence of hepatitis A virus antibodies in hospital personnel].
    Abb J
    Gesundheitswesen; 1994 Jul; 56(7):377-9. PubMed ID: 7919699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of hepatitis A antibodies among Israeli travellers and the economic feasibility of screening before vaccination.
    Schwartz E; Raveh D
    Int J Epidemiol; 1998 Feb; 27(1):118-20. PubMed ID: 9563704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of vaccination against hepatitis A in travellers.
    Van Doorslaer E; Tormans G; Van Damme P
    J Med Virol; 1994 Dec; 44(4):463-9. PubMed ID: 7897383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The value of screening serology in anti-hepatitis A vaccination of travelers].
    Landry P; Darioli R
    Schweiz Med Wochenschr; 1998 Apr; 128(15):581-5. PubMed ID: 9606799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence of anti-hepatitis A in patients with chronic liver disease].
    Diago M; Luján M; García V; Cors R; Carbonell P; Tuset C; Gimeno J
    Gastroenterol Hepatol; 1998; 21(7):324-6. PubMed ID: 9808894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis A antibody titres after infection and immunization: implications for passive and active immunization.
    Zaaijer HL; Leentvaar-Kuijpers A; Rotman H; Lelie PN
    J Med Virol; 1993 May; 40(1):22-7. PubMed ID: 8515245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Annual epidemics of hepatitis A in four large cities related to holiday travel among immigrant children].
    van Gorkom J; Leentvaar-Kuijpers A; Kool JL; Coutinho RA
    Ned Tijdschr Geneeskd; 1998 Aug; 142(34):1919-23. PubMed ID: 9856179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis A infection: a seroepidemiological study in young adults in North-East Italy.
    Moschen ME; Floreani A; Zamparo E; Baldo V; Majori S; Gasparini V; Trivello R
    Eur J Epidemiol; 1997 Dec; 13(8):875-8. PubMed ID: 9476815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of hepatitis a antibodies in western Indian population: changing pattern.
    Chitambar SD; Chadha MS; Joshi MS; Arankalle VA
    Southeast Asian J Trop Med Public Health; 1999 Jun; 30(2):273-6. PubMed ID: 10774693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The efficacy of the prevaccination detection of anti-HAV in hepatitis A vaccination programs].
    Navas E; Bayas JM; Bruguera M; Vidal J; Galí N; Taberner JL; Salleras L
    Med Clin (Barc); 1995 Jul; 105(5):168-71. PubMed ID: 7630228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness analysis of hepatitis A prevention in travellers.
    Tormans G; Van Damme P; Van Doorslaer E
    Vaccine; 1992; 10 Suppl 1():S88-92. PubMed ID: 1335668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility to hepatitis A virus infection among chronic liver disease patients and healthy blood donors in Thailand.
    Pramoolsinsap C; Attamasirul K; Busagorn N; Maneerat Y; Nuchprayoon C; Tanprasert S; Srivatanakul P; Theamboonlers A; Hirsch P; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 1999 Mar; 30(1):91-5. PubMed ID: 10695795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of the efficiency of the screening of anti-HVA IgG antibodies before active or passive immunization].
    Arnal Alonso JM; Frisas Clavero O; Garuz Bellido R; Forcen Alonso T
    Rev Sanid Hig Publica (Madr); 1995; 69(1):71-8. PubMed ID: 7644884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.